Anat Horev

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

Raul G. Nogueira, Muhammad M. Qureshi, Mohamad Abdalkader et al. · Neurology · 2021 · 154 citations · Full text

Life Sciences, Health Sciences, Global Health +13

Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes

Rishi Gupta, Anat Horev, Thanh N. Nguyen et al. · Journal of NeuroInterventional Surgery · 2012 · 141 citations

Medicine, Neurological Surgery, Surgery +17

Predictors of Good Outcome After Endovascular Therapy for Vertebrobasilar Occlusion Stroke

Mehdi Bouslama, Diogo C Haussen, Amin Aghaebrahim et al. · Stroke · 2017 · 134 citations

Medicine, Neurology, Neurosurgery +17

Advanced modality imaging evaluation in acute ischemic stroke may lead to delayed endovascular reperfusion therapy without improvement in clinical outcomes

Kevin N. Sheth, John B. Terry, Raul G. Nogueira et al. · Journal of NeuroInterventional Surgery · 2012 · 109 citations · Full text

Medicine, Neurology, Radiology +17